Letter to the Editor Regarding “Real‐World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study”

Ähnliche Einträge

• Real‐World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study
  von: Tadakazu Hisamatsu, et al.
  Veröffentlicht: (2025)
• Letter to the Editor: Comparative Efficacy and Safety of 0.8‐L Versus 2‐LPolyethylene Glycol‐Ascorbic Acid Solutions in ColonoscopyPreparation: A Prospective, Multicenter, Randomized, and Controlled Trial
  von: Xingmei Yin, et al.
  Veröffentlicht: (2026)
• Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate‐to‐Severe Ulcerative Colitis or Crohn’s Disease
  von: Agata Michalak, et al.
  Veröffentlicht: (2026)
• Letter to the Editor: Five‐Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment
  von: Zanzan Zhao, et al.
  Veröffentlicht: (2025)
• Letter to the Editor Regarding “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection”
  von: Parena Maheshwari
  Veröffentlicht: (2025)